Bavarian Nordic (OTCMKTS:BVNRY) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?
by Renee Jackson · The Cerbat GemShares of Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $9.94 and traded as high as $10.41. Bavarian Nordic shares last traded at $10.41, with a volume of 3,111 shares trading hands.
Bavarian Nordic Trading Up 0.4%
The stock has a market cap of $2.48 billion, a PE ratio of 11.88 and a beta of 1.27. The company’s 50 day moving average is $9.95 and its 200-day moving average is $10.36.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last posted its quarterly earnings data on Thursday, March 12th. The company reported ($0.20) earnings per share for the quarter. Bavarian Nordic had a net margin of 22.20% and a return on equity of 11.27%. The firm had revenue of $226.16 million during the quarter. As a group, analysts forecast that Bavarian Nordic will post 0.67 EPS for the current year.
About Bavarian Nordic
Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.
The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.